PepTivator® Parvovirus B19 VP1u

PepTivator® Parvovirus B19 VP1u is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the complete VP1u domain (aa 1-227) of the VP1 protein, (UniProt ID: Q9PZT0).

In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Related products for PepTivator® Parvovirus B19 VP1u

Specifications for PepTivator® Parvovirus B19 VP1u
Overview

PepTivator® Parvovirus B19 VP1u is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the complete VP1u domain (aa 1-227) of the VP1 protein, (UniProt ID: Q9PZT0).

In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Detailed product information
Background information

Parvovirus B19 is a small, non-enveloped DNA virus belonging to the Parvoviridae family and the Erythroparvovirus genus. It is the etiologic agent of erythema infectiosum (fifth disease), a common childhood illness characterized by a “slapped cheek” rash and other flu-like illnesses. The parvovirus B19 capsid is composed of two major structural proteins: VP1 and VP2. VP1 differs from VP2 only in a unique N-terminal extension composed of 227 aa, known as the VP1 unique region (VP1u). This VP1u domain plays a critical role in the viral life cycle and immunogenicity. Moreover, VP1u is a prominent target of the host immune response and has been shown to induce strong T cell and antibody responses, making it a valuable component for immunological assays and vaccine research.

The PepTivator Peptide Pools have been specially developed for efficient in vitro Stimulation of antigen-specific CD4+ and CD8+ T cells, as peptides of 15 amino acid length with 11 amino acid overlap represent the optimized solution for stimulating both CD4+ and CD8+ T cells in various applications. Stimulation of T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and upregulation of activation markers, which then allows the detection or isolation of antigen-specific T cells. Quantitative, phenotypical, or functional analysis of antigen-specific T cell immunity can provide important information on the natural course of the natural course of immune responses.

You have previously chosen International as your location.
What do you want to do?